What are the best cannabis stocks to buy?
Cannabis stocks have been creating quite a buzz on the stock market. Ever since the substance was legalised as a medicinal product, many cannabis-based companies have emerged. Moreover, with the sector expected to reach $95 billion in 2026, I believe it is an excellent opportunity for investors like me to jump on the bandwagon right now.
I have previously discussed the investment worthiness of the cannabis stock, Kanabo. However, I’ve spotted another two, which I think are a great buy today for my portfolio.
The largest hydroponics supplier
GrowGeneration (NASDAQ:GRWG) is the largest hydroponics supplier in the United States, with a network of 58 stores in twelve states. Founded in 2014, the company has been on a growing streak since the demand for cannabis-based products spiked. As a result, its revenues have more than doubled in the last three years.
|Year||Total Revenue ($m)||Percentage Change|
GrowGeneration is taking advantage of the recently accelerated push towards e-commerce solutions. Online sales last year came in at $10.6m. Today they are 120% higher as the firm continues to improve its online shopping experience for users.
This rapid growth has raised management’s expectations regarding revenue. And now, the company expects the gross income to reach $475m by the end of its 2021 fiscal year. Moreover, as part of its expansion-based growth strategy, the hydroponics supplier has added 14 new locations to its portfolio, further increasing its market presence.
Today, this cannabis stock is trading at $27.60 per share. But that comes after some substantial decline throughout 2021. And yet, despite this, the prices to earnings ratio still sits around 90. Needless to say, that’s quite a lofty valuation. With such high expectations from investors, the slightest sign of trouble could trigger some significant volatility. However, personally, I think the risk is worth the potential reward. Therefore I’m still tempted to buy this cannabis stock for my portfolio.
A leading global cannabis stock
Cronos Group (NASDAQ:CRON) is an innovative global cannabinoid company focused on cannabis research, technology and product development. And just like GrowGeneration, the firm has achieved some commendable growth, with revenues more than doubling in the last three years.
|Year||Total Revenue ($m)||Percentage Change|
The Cronos group plans to develop a diversified global sales and distribution network by establishing an efficient global supply chain. To achieve this, the company recently announced a strategic investment in PharmaCann – an expert in growing, processing, and dispensing cannabis products. Through the broad geographic footprint of PharmaCann, in the US, which includes six production facilities and 24 dispensaries, the cannabinoid company plans to extend its distribution channel.
As promising as this sounds, the firm also has a lofty valuation to maintain. So far this year, the stock price has reached a high of $15.83 and a low of $4.92. This level of volatility adds considerable risk to an investment in this business. But once again, given the growth potential, this risk may be worth it, in my mind.
Final words on cannabis stock investments
The cannabis sector is still relatively young. And as an investor, I like to get into big opportunities as early as possible to reap the biggest rewards. The industry has a lot of hurdles to overcome, especially on the regulatory front. And this may impede the overall growth rate.
But in my opinion, these two cannabis stocks look like they can overcome these challenges. And while they are a bit expensive today, they could yield some pretty significant returns over the long term.
Top US Growth Stock for 2021
Are you on the lookout for US growth stocks? If so, get this FREE report now and discover what I think is one of the best growth opportunities of the decade.
Covid-19 has devastated the global markets. But this stock has been thriving and has doubled its revenue for the last five years, even in 2020! What's more, due to the recent volatility in the stock market, The Money Cog analysts feel the stock is grossly undervalued.
Needless to say, I believe it's a fantastic business that could become an industry leader in the future!
Saima Naveed does not own shares in any of the companies mentioned. The Money Cog has no position in any of the companies mentioned. Views expressed on the companies and assets mentioned in this article are those of the writer and therefore may differ from the opinions of analysts in The Money Cog Premium services.